BC Innovations | Feb 26, 2009
Distillery Therapeutics

Indication: Ophthalmic disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Ophthalmic disease Ophthalmic; dental Cyclin M4 (CNNM4) Genomewide haplotype analysis identified mutations in CNNM4 that could be targeted to help...
BC Innovations | Feb 26, 2009
Distillery Therapeutics

Indication: Ophthalmic disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Ophthalmic disease Ophthalmic; dental Cyclin M4 (CNNM4) A genetic study in humans suggests that mutations in CNNM4 may be useful...
Items per page:
1 - 2 of 2